From January 1, 2022 to March 31, 2022, the company has repurchased 7,133,700 shares, representing 0.46% for ¥24,992.76 million. With this, the company has completed the repurchase of 22,469,400 shares, representing 1.43% for ¥74,972.7 million under the buyback announced on October 28, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,053 JPY | -1.12% | -2.17% | -0.02% |
04-30 | Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion | RE |
04-26 | EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.02% | 41.63B | |
+33.43% | 700B | |
-5.12% | 358B | |
+19.59% | 330B | |
+4.89% | 287B | |
+15.85% | 236B | |
+6.75% | 202B | |
-9.12% | 197B | |
+4.26% | 161B | |
-3.54% | 157B |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- Tranche Update on Takeda Pharmaceutical Company Limited's Equity Buyback Plan announced on October 28, 2021.